A Phase 1 Study of LY2874455 in Participants With Advanced Cancer

Clinical trial NCT01212107 · COMPLETED

Trial details

NCT number: NCT01212107
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2010-12-01
Primary completion: 2014-08-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.